Sight Sciences, Inc. (SGHT): Operating Income

Annual figures by period end, from SEC filings.

-$37.10M

Year ended 2025-12-31

-$27.87M

Trailing 12 months to 2026-06-30

2020-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$37.10M	n/m	2026-03-04, From 2025-01-01
2024-12-31	-$50.53M	n/m	2026-03-04, From 2024-01-01
2023-12-31	-$57.27M	n/m	2025-03-07, From 2023-01-01
2022-12-31	-$83.95M	n/m	2024-03-13, From 2022-01-01
2021-12-31	-$51.48M	n/m	2023-03-16, From 2021-01-01
2020-12-31	-$32.19M	n/a	2022-03-24, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Sight Sciences, Inc. (SGHT)	2025-12-31	-$37.10M	n/m
PRO DEX Inc (PDEX)	2026-06-30	$12.99M	+21.5%
TELA Bio, Inc. (TELA)	2025-12-31	-$33.76M	n/m
AVITA Medical, Inc. (RCEL)	2025-12-31	-$42.53M	n/m
Iradimed Corp (IRMD)	2025-12-31	$26.15M	+19.0%
Delcath Systems, Inc. (DCTH)	2025-12-31	$660.0K	n/m
Pulmonx Corp (LUNG)	2025-12-31	-$53.66M	n/m
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	-$134.74M	n/m
Meihua International Medical Technologies Co., Ltd. (MHUAF)	2025-12-31	$8.28M	-42.1%

Compare SGHT, PDEX, TELA, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗